Search

Your search keyword '"Bullock MD"' showing total 33 results

Search Constraints

Start Over You searched for: Author "Bullock MD" Remove constraint Author: "Bullock MD"
33 results on '"Bullock MD"'

Search Results

1. Optimal Initial Intravenous Loop Diuretic Dosing in Acute Decompensated Heart Failure

2. The tale of 2 pancreases: Jejunal mesenteric ectopic pancreas causing recurrent ectopic pancreatitis

3. FDG PET/CT and thyroid biopsy leads to neurosarcoidosis diagnosis

4. Breast Pain Differential: Mondor’s Disease of the Breast

6. Margin Sampling and Survival Outcomes in Oral Cavity and p16-Positive Oropharyngeal Squamous Cell Carcinoma

7. A Multi-step Approach to Adapting a Mind-Body Resiliency Intervention for Fear of Cancer Recurrence and Uncertainty in Survivorship (IN FOCUS)

8. Treatment Choices in Managing Bethesda III and IV Thyroid Nodules: A Canadian Multi-institutional Study

9. Obsessive-Compulsive Disorder Presenting as Gender Dysphoria/Gender Incongruence: A Case Report and Literature Review

10. Brain Injury Medicine : Principles and Practice

12. Consensus Approach to a Treat-to-target Strategy in Juvenile Idiopathic Arthritis Care: Report From the 2020 PR-COIN Consensus Conference.

14. Exosomal microRNAs (exomiRs): Small molecules with a big role in cancer.

15. Surgical Management for Prostate Cancer.

16. Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression.

17. Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications.

18. The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.

19. MicroRNAs in Testicular Cancer Diagnosis and Prognosis.

20. Translational aspects in targeting the stromal tumour microenvironment: from bench to bedside.

21. The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.

22. Long Non-Coding RNAs in Endometrial Carcinoma.

23. Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future.

24. Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer.

25. A top-down view of the tumor microenvironment: structure, cells and signaling.

26. Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.

27. Estrogen and breast cancer: can less mean more?

28. Molecular profiling of the invasive tumor microenvironment in a 3-dimensional model of colorectal cancer cells and ex vivo fibroblasts.

29. miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance.

30. FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role.

31. Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression.

32. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression.

33. Intradural extramedullary primary malignant melanoma radiographically mimicking a neurofibroma.

Catalog

Books, media, physical & digital resources